A health worker injects a person during clinical trials for a Covid-19 vaccine at Research Centers of America in Hollywood, Florida, U.S., on Wednesday, Sept. 9, 2020. Drugmakers racing to produce Covid-19 vaccines pledged to avoid shortcuts on science as they face pressure to rush a shot to market. Photographer: Eva Marie Uzcategui/Bloomberg via Getty Images
What to Know
The FDA’s vaccine advisory panel approved Pfizer’s COVID vaccine — one of the final steps before millions of doses of the shot can be delivered across the country
New York Gov. Andrew Cuomo said the state will receive its first deliveries of COVID-19 vaccine Sunday or Monday as the pandemic is landing more patients into hospitals across the state
New York City is slated to receive an estimated 72,000 doses — the most for any region in the state. Long Island will receive the second highest
Two vaccine candidates stumbled Friday in the race among researchers to combat Covid-19, a setback for the global immunisation effort even as the Pfizer-BioNTech jab neared approval in the US.
The mixed news on the vaccine front comes as infections accelerated fast in North America and parts of Africa but started to stabilise in Europe and drop in Asia and the Middle East.
Around the world more than 1.58 million lives have been lost to Covid-19 since it emerged in China a year ago, according to an AFP tally from official sources.
A woman walks past a costume rental store, with Santa Claus outfits outside, on December 10, 2020 in Paris as France is on a second lockdown in a bid to contain the spread of Covid-19 pandemic caused by the novel coronavirusPhoto: AFP / JOEL SAGET
While the record-fast development of vaccine options has brought hope to the